JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.34% |
| 2 | Technology | 11.83% |
| 3 | Healthcare | 9.48% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
2176
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $7.11M | ﹤0.01% |
228,612
-3,950
| -2% | -$119K |
|
2177
PUT
Simon Property Group
SPG
$71B
| $7.08M | ﹤0.01% |
43,800
| – | – |
|
2178
Mine Safety
MSA
$7.44B
| $7.08M | ﹤0.01% |
87,602
+38,337
| +78% | +$2.87M |
|
|
CUNB
2179
DELISTED
CU Bancorp
CUNB
| $7.07M | ﹤0.01% |
181,636
+4,591
| +3% | +$167K |
|
2180
VEON
VEON
$3.9B
| $7.06M | ﹤0.01% |
68,873
-21,385
| -24% | -$2.18M |
|
2181
Lifetime Brands
LCUT
$221M
| $7.05M | ﹤0.01% |
376,800
-4,760
| -1% | -$85.5K |
|
2182
PUT
Puma Biotechnology
PBYI
$453M
| $7.04M | ﹤0.01% |
+60,000
| New | +$5.58M |
|
2183
Amphastar Pharmaceuticals
AMPH
$869M
| $7.04M | ﹤0.01% |
393,375
-13,250
| -3% | -$218K |
|
2184
CALL
Parker-Hannifin
PH
$134B
| $7.03M | ﹤0.01% |
40,000
+33,200
| +488% | +$5.45M |
|
2185
PUT
Exelixis
EXEL
$12.7B
| $7.03M | ﹤0.01% |
290,000
| – | – |
|
2186
CALL
Vodafone
VOD
$36.7B
| $7.01M | ﹤0.01% |
250,000
| – | – |
|
|
CAMP
2187
DELISTED
CalAmp Corp.
CAMP
| $7.01M | ﹤0.01% |
14,438
+6,705
| +87% | +$2.96M |
|
|
HES
2188
CALL
DELISTED
Hess
HES
| $6.98M | ﹤0.01% |
+150,000
| New | +$6.34M |
|
|
AUY
2189
DELISTED
Yamana Gold, Inc.
AUY
| $6.97M | ﹤0.01% |
2,554,859
+2,518,697
| +6,965% | +$6.7M |
|
2190
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.95B
| $6.97M | ﹤0.01% |
152,094
+150,963
| +13,348% | +$6.66M |
|
|
GPOR
2191
DELISTED
Gulfport Energy Corp.
GPOR
| $6.97M | ﹤0.01% |
484,147
+247,103
| +104% | +$3.21M |
|
2192
Telecom Argentina
TEO
$5.81B
| $6.96M | ﹤0.01% |
228,135
+188,465
| +475% | +$5.54M |
|
|
SPN
2193
DELISTED
Superior Energy Services, Inc.
SPN
| $6.96M | ﹤0.01% |
64,516
-8,914
| -12% | -$880K |
|
|
MYOK
2194
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $6.94M | ﹤0.01% |
163,075
-313,500
| -66% | -$10M |
|
2195
Columbia Banking Systems
COLB
$8.97B
| $6.93M | ﹤0.01% |
163,179
-19,149
| -11% | -$740K |
|
2196
Gray Television
GTN
$490M
| $6.92M | ﹤0.01% |
451,934
-9,676
| -2% | -$138K |
|
|
AAV
2197
DELISTED
Advantage Oil & Gas Ltd
AAV
| $6.91M | ﹤0.01% |
1,080,042
-50,033
| -4% | -$330K |
|
2198
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
| $6.9M | ﹤0.01% |
143,711
+6,297
| +5% | +$297K |
|
|
GBT
2199
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $6.86M | ﹤0.01% |
232,621
-3,054
| -1% | -$85.9K |
|
2200
Bio-Rad Laboratories Class A
BIO
$9.53B
| $6.86M | ﹤0.01% |
30,855
+5,823
| +23% | +$1.31M |
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 502 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 502 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.